Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stanford V and EBVP Regimens in Hodgkin's Disease and HIV Infection
NCT00003262Phase 2Unknown
- Sponsor
- Centro di Riferimento Oncologico di Aviano
- Start
- May 1997
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Stanford V, EBVP regimen in Hodgkin lymphoma (HL), sponsored by Centro di Riferimento Oncologico di Aviano. Status: unknown.
02
Drugs
Stanford VEBVP regimen
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00003262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003262.